Indian Pharmaceutical Supplier to Sri Lanka.
India already accounts for roughly 61 per cent of Sri Lankan medicine imports by shipment count, and the State Pharmaceutical Corporation actively solicits Indian bids through the Colombo High Commission. M Care has run the Mumbai-Colombo lane since our earliest export years. If you are an SPC tender desk, an NMRA-registered importer, a private-hospital procurement officer at Asiri or Nawaloka, or a Ministry of Health buyer working on Indian Line of Credit medicines, this page is the operational summary of how we actually deliver.
The NMRA framework, Indian-side.
The National Medicines Regulatory Authority (NMRA) is the single licensing gate for human medicines in Sri Lanka. NMRA accepts WHO-GMP as the manufacturing-site standard, with Marketing Authorisation valid for five years. CDSCO Certificates of Pharmaceutical Product issued in WHO format are routinely accepted. Indian manufacturing sites that hold concurrent WHO-PQ on a molecule pass NMRA scrutiny faster.
On the procurement side, the State Pharmaceutical Corporation (SPC) is the state-sector tender body for the Ministry of Health. SPC publishes tenders on spc.lk and in the Sunday Observer, and routes specific Indian-supplier solicitations through the Indian High Commission in Colombo. Indian Line of Credit medicines, settled in INR via the SBI vostro mechanism, have run since the 2022 currency crisis and are still active for selected molecules.
Private-sector flow is separate. Asiri Hospital Group, Nawaloka, Hemas and Lanka Hospitals procure independently from licensed importers. Retail pharmacy chains (Healthguard, Lina, Union Chemists) work through wholesalers with NMRA registration. We supply both channels, and our manufacturing partners hold concurrent WHO-PQ where the molecule profile demands it.
Macroeconomic context matters: Sri Lanka has been in IMF programme conditions since 2023 and SPC payment cycles have run 6 to 12 months on certain tenders during the worst of the crisis. We price every quote with that reality factored in, and have covered the FX-exposure window with documentary LCs for first-time buyers rather than relying on open account.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six fronts we work, end to end.
SPC tender response
Full-stack SPC tender bids assembled from Mumbai: NMRA dossier file, batch-specific stability data, pack-size variations, and the cost-and-freight schedule SPC actually wants on its e-procurement template. Most submissions turn around in 5 to 7 working days from the tender drop.
NMRA registration support
End-to-end NMRA Marketing Authorisation packs, CTD-format dossier, manufacturer site registration and per-product files. Typical first-time registration on a generic molecule runs 9 to 14 months from file submission to MA grant; renewals are quicker.
Private hospital chain supply
Routine and emergency supply into Asiri, Nawaloka, Hemas and Lanka Hospitals' central procurement. Cold-chain biologicals, oncology injectables, ICU paralytics and specialty injectables; weekly call-off against a rolling forecast where demand justifies it.
Indian Line of Credit medicines
INR-settled supply under the Indian Line of Credit framework, when the buyer counterparty is on the approved list. Same WHO-GMP product as our hard-currency lanes; documentation routed through SBI's Colombo branch and the Indian High Commission.
Donor-funded procurement
WHO-PQ-eligible supply into Global Fund, UNICEF and Gavi-routed Sri Lanka programmes. Anti-malarials, anti-TB regimens, paediatric ARVs and EPI vaccines through documented Q-channels with destination-language pack inserts.
Air and sea freight to Colombo
Mumbai-Colombo pharma is short-haul: 3 to 4 days door-to-door by sea via Colombo Port, daily air via SriLankan Cargo and Air India direct. Cold-chain on validated Envirotainer / Pelican BioThermal lanes with Sensitech logging through to receiving warehouse.
How stock actually clears Bandaranaike or Colombo Port.
Sri Lanka is one of the easiest international lanes Indian pharma runs. The default freight pattern is short-haul air, BOM to CMB on SriLankan Cargo or Air India direct, four to six hours wheels-up to wheels-down. Dispatch cut-off at Mumbai is 16:00 IST for next-morning availability at Bandaranaike Cargo; clearance at the airport pharma facility, NMRA inspection where required, and onward despatch to the importer's bonded store typically close door-to-door at 36 to 60 hours.
For palletised ambient supply the sea route is Mumbai (Nhava Sheva) to Colombo Port, a three-to-four-day transit on direct services from carriers including Maersk, MSC and CMA CGM. Customs clearance under Sri Lanka Customs typically runs two to three working days for compliant CTD-backed pharma cargo. Cold-chain shipments use validated Envirotainer RKN e1 for 2 to 8 degree celsius bulk and Pelican BioThermal Credo Cube or Sofrigam TPi passive solutions for smaller consignments, with continuous Sensitech TempTale data appended to the airway bill.
Commercial terms on a first engagement are typically a hundred per cent telegraphic transfer against pre-shipment documents, or a documentary LC at sight where the buyer is an SPC-vetted importer. From order two onwards, terms migrate to LC at sight or open account thirty days, with longer tenors opening up once the relationship and FX-exposure profile settle. We invoice in USD as the standard, with INR available under the Line of Credit channel.
Where Sri Lankan demand actually concentrates.
Sri Lankan procurement is not a one-shape-fits-all formulary. SPC tenders cover the WHO Essential Medicines List backbone, with cardiovascular, anti-infectives and cancer-care lines as the volume drivers. Private-hospital chains buy a different shelf: more biologics, more specialty injectables, more imported branded generics on the private outpatient side. Donor-funded programmes (Global Fund, UNICEF, Gavi) add the third buyer profile.
Our highest-volume Sri Lankan therapy areas are oncology (paclitaxel, gemcitabine, oxaliplatin, the carboplatin/cisplatin block, and a growing biosimilar bench), cardiovascular (statins, ACE inhibitors, beta-blockers, the DOAC bench) and anti-infectives (carbapenems, glycopeptides, antifungals, broad-spectrum oral antibiotics). The cold-chain biologic line, mostly insulin analogues and oncology biosimilars, is the fastest-growing slice.
Diabetes therapy is structurally important: prevalence is rising and Sri Lanka imports almost all of its insulin. Anti-TB, anti-malarial and ARV lines run through donor-funded procurement on WHO-PQ standards. We hold capability on every category SPC currently tenders, and are explicit about which therapy areas we are not yet competitive on, rather than bidding cheaply on a line we cannot back with stock.
A private Colombo hospital group came to us in 2024 needing emergency supply on a third-line antibiotic when their European supplier disrupted on a single-line shortage. We identified an NMRA-registered SKU from one of our Hyderabad partners, prepared destination-language artwork and shipped a validated trial batch from Mumbai to Bandaranaike inside seven working days. The hospital carried the molecule forward on a six-month standing order, and added two further anti-infective lines once the cold-chain audit cleared. Stockout incidents in twelve months: zero.
Why M Care, specifically.
India is already the dominant pharmaceutical source for Sri Lanka by shipment count, so the question is not whether Indian pharma works, it is which Indian counterparty delivers on time, holds documentation that NMRA actually accepts, and prices in the FX reality the buyer is living in. M Care brings the Mumbai HQ as the source-of-supply, a Hindi-Sinhala-English-comfortable working language register on phone and WhatsApp, and a long-running SBI relationship that lets us settle in INR on the Indian Line of Credit channel where the buyer is approved.
On the documentation side, our NMRA filings come pre-formatted in CTD with Sri-Lanka-specific artwork and pack-insert variants where the molecule profile requires it. On the operational side, our cold-chain track record runs on validated BOM-CMB lanes with continuous Sensitech logging to the receiving NMRA-registered importer's warehouse. We do not quote prices we cannot hold for sixty to ninety days, and we will tell you at the enquiry stage if our manufacturing partner cannot make a tender-required deadline rather than walk you into a supply gap.
What Sri Lankan buyers ask us first.
Are your Indian manufacturing partners NMRA-registered?
Yes, on every molecule we actively quote into Sri Lanka. NMRA accepts WHO-GMP as the manufacturing standard and routinely accepts CDSCO-issued Certificates of Pharmaceutical Product. We can provide the latest WHO-GMP inspection report, Site Master File extract and batch Certificate of Analysis ahead of any trial order so your QA lead can sign off before a purchase order is raised.
How do you respond to State Pharmaceutical Corporation tenders?
The Mumbai desk assembles the full SPC submission: NMRA-format dossier file, batch-specific stability data, pack-size variations, cost-and-freight schedule and the SPC e-procurement template. Most tender responses turn around in 5 to 7 working days from tender drop. We will not bid on an SPC line we cannot hold stock against for the contract duration.
Do you settle in INR under the Indian Line of Credit framework?
Yes, where the buyer counterparty is on the approved list and the molecule is eligible. Settlement runs through SBI's Colombo branch with documentation co-ordinated via the Indian High Commission. Same WHO-GMP product, same NMRA-registered manufacturing partner; the only change is the settlement currency and the documentation channel.
What is the lead time on a Mumbai to Colombo shipment?
Air via SriLankan Cargo or Air India direct: 36 to 60 hours door-to-door. Sea via Mumbai (Nhava Sheva) to Colombo Port on Maersk, MSC or CMA CGM: 3 to 4 days transit plus 2 to 3 days clearance. Cold-chain on validated Envirotainer or Pelican BioThermal lanes with continuous Sensitech logging.
Can you supply private hospital chains as well as the State sector?
Yes. Private hospital chains (Asiri, Nawaloka, Hemas, Lanka Hospitals) procure independently from licensed importers, and we supply that channel directly. The product is the same WHO-GMP source as the State channel; the documentation pack adapts to the importer's QA requirements, and pricing reflects volume and pack-mix differences between State and private buyers.
Do you supply WHO-PQ products into donor-funded Sri Lanka programmes?
Yes. Our manufacturing partners hold concurrent WHO Prequalification on selected anti-malarial, anti-TB, paediatric ARV and EPI vaccine SKUs. Supply runs through documented Q-channels with destination-language pack inserts and full chain-of-custody documentation, into Global Fund, UNICEF and Gavi-routed programmes.
How do you handle the post-2022 FX situation in Sri Lanka?
We price every quote with the IMF-programme reality factored in. First-time buyers settle by hundred-per-cent TT against pre-shipment documents or by documentary LC at sight; established relationships move to open account 30 days, with longer tenors opening up as the relationship and the FX-exposure window settle. INR settlement is available where the buyer is approved on the Indian Line of Credit list.
Why Sri Lankan buyers choose M Care.
NMRA-fluent documentation
CTD-format NMRA filings with Sri-Lanka-specific artwork and pack-insert variants. Our manufacturing partners hold WHO-PQ on selected molecules; CDSCO CoPP issued in WHO format on the rest.
Mumbai to Colombo, short-haul
Direct air on SriLankan Cargo and Air India, 36 to 60 hours door-to-door. Cold-chain on validated Envirotainer and Pelican BioThermal lanes with continuous Sensitech logging.
INR or USD settlement, your call
USD invoicing as the standard; INR settlement under the Indian Line of Credit framework where the buyer counterparty is approved. SBI Colombo branch handles the documentation chain.
Top categories we ship to Sri Lanka
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ hospital and retail lines.
Oncology
Paclitaxel, gemcitabine, oxaliplatin, carboplatin, cisplatin, biosimilars and supportive-care lines.
Cardiovascular
Antihypertensives, statins, anticoagulants, antiarrhythmics and heart-failure lines.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid and hormonal therapy — 470+ lines.
Respiratory
Inhalers, nebuliser solutions, ICS-LABA combinations — 117+ SKUs.
General & OTC
Analgesics, vitamins, wound-care, nutritionals — 1,283 SKUs.
Routes that sit behind this market.
WHO-GMP compliance
Manufacturer registration, Site Master File support and batch CoA documentation that NMRA actually accepts on first pass.
CTD dossier preparation
NMRA-ready CTD dossiers from Indian WHO-GMP manufacturing sites; submission-ready packs with destination-language artwork.
Cold-chain validated supply
Validated 2 to 8 degree celsius and minus 25 degree celsius lanes from Mumbai to Colombo, with continuous temperature logging.
Molecule, volume, ship-to. One working day to a quote.
Your enquiry goes directly to the account manager responsible for the Sri Lanka desk. No call-centre hops, no generic auto-responders, just the answer an SPC tender desk or hospital procurement officer can act on.
Start a Sri Lanka enquiry → Back to all markets